v3.25.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 8,203,691 $ 4,069,766
General and administrative 4,309,551 3,972,140
Total operating expenses 12,513,242 8,041,906
Loss from operations (12,513,242) (8,041,906)
Other income and expenses:    
Interest income 225,781 247,216
Net loss $ (12,287,461) $ (7,794,690)
Net loss per share of common stock, basic and diluted $ (8.03) $ (39.99)
Weighted-average basic and diluted common shares 1,529,772 194,928

Source